top of page

OncoRes Medical receives $12.5M in latest funding to pursue clinical trials

Updated: Aug 21

24 May 2022 / Adam Ang / MobiHealth News

OncoRes medical device. (Supplied)

The company develops a breakthrough device for detecting residual cancer tissues.

Perth-based medical device firm OncoRes Medical has bagged $12.5 million in funding to support its upcoming clinical trials.

This article was first published by MobiHealth News. Click here for full article.

7 views0 comments
bottom of page